Feifei Li

机构：Liaoning Cancer Hospital & Institute, China Medical University · ORCID：0000-0002-1321-3385

发表论文 78 篇 · 总被引 1884 次 · h-index 22

代表论文

• Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease (2023 · Journal of the American College of Cardiology · 被引 44)
• Pathway Evolution Through a Bottlenecking‐Debottlenecking Strategy and Machine Learning‐Aided Flux Balancing (2024 · Advanced Science · 被引 25)
• Sleep duration and risk of stroke and coronary heart disease: a 9-year community-based prospective study of 0.5 million Chinese adults (2023 · BMC Neurology · 被引 19)
• Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages (2025 · European Heart Journal · 被引 13)
• Promoting collateral formation in type 2 diabetes mellitus using ultra-small nanodots with autophagy activation and ROS scavenging (2024 · Journal of Nanobiotechnology · 被引 10)
• Association between health insurance cost-sharing and choice of hospital tier for cardiovascular diseases in China: a prospective cohort study (2024 · The Lancet Regional Health - Western Pacific · 被引 10)